GT BIOPHARMA, INC. (GTBP) Operating income 2016–2025
GT BIOPHARMA, INC. (GTBP) annual operating income history from SEC filings — each fiscal year as reported.
-$12.4MFY2025 · since FY2016: -$9.4M → -$12.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.4M | +13.5% |
| FY2024 | -$14.4M | -5.8% |
| FY2023 | -$13.6M | +36.1% |
| FY2022 | -$21.3M | +63.0% |
| FY2021 | -$57.5M | -750.3% |
| FY2020 | -$6.8M | -142.1% |
| FY2019 | $16.1M | +106.4% |
| FY2018 | -$250.1M | -84.5% |
| FY2017 | -$135.6M | -1346.2% |
| FY2016 | -$9.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice